CAROLINE FLAKE: Open Payments
NPI 1346720596 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,878 in 103 payments from 41 companies in 2025. Trend: 2023 $1,083 · 2024 $1,968 · 2025 $2,878
Food & beverage: $2,778Education: $100
| Company | Payments | Amount |
|---|---|---|
| Kite Pharma, Inc. | 7 | $362 |
| Sobi, Inc | 4 | $282 |
| Merck Sharp & Dohme LLC | 8 | $184 |
| Astellas Pharma US Inc | 4 | $171 |
| PFIZER INC. | 8 | $169 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $158 |
| Novartis Pharmaceuticals Corporation | 5 | $143 |
| Janssen Biotech, Inc. | 6 | $140 |
| ABBVIE INC. | 5 | $113 |
| E.R. Squibb & Sons, L.L.C. | 4 | $80 |
Products named: Yescarta, Vonjo, KEYTRUDA, ELREXFIO, SCEMBLIX, REBLOZYL, LIBTAYO, ZEPZELCA.
Industry payments across SC — which companies pay providers there.
